RxDoctor Payments Data

Jennifer Veneris

Hematology & Oncology · Chicago, ILNPI 1467716977

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $3,193 of the $3,193 with a category attached, or 100.0%. F. Hoffmann-la Roche AG accounts for 92.9% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for hematology & oncology clinicians in IL, where the typical reported total is $2,365.

$3,193in general payments, 2019–2025

Across 3 payments — averaging $1064.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • F. Hoffmann-la Roche AG$3K
  • Foundation Medicine, Inc.$228
$1,157,932in research payments, 2019–2025

Across 32 payments — averaging $36,185 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Corcept Therapeutics$869K
  • Merck$289K

What the payments were for

  • Speaking & faculty fees$3,193100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
F. Hoffmann-la Roche AG1$2,965
Foundation Medicine, Inc.2$228

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,193 in reported general payments places this provider in the 50th percentile of 580 hematology & oncology providers in Illinois.

See all hematology & oncology providers in Illinois

Other hematology & oncology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →